REFERENCES
1. Finn CA. Why do women menstruate? Historical and evolutionary review. Eur J Obstet Gynecol Reprod Biol 1996;70:3-8.
2. Strassmann BI. The evolution of endometrial cycles and menstruation.
Q Rev Biol 1996;71:181-220.3. Finn CA. Menstruation: a nonadaptive consequence of uterine evolution. Q Rev Biol 1998;73:163-73.
4. Maybin JA, Critchley HO. Menstrual physiology: implications for endometrial pathology and beyond. Hum Reprod Update 2015;21:748-61.
5. Crawford P. Attitudes to menstruation in seventeenth-century England. Past Present 1981;91:47-73.
6. Sharma S. Women hail menstruating ruling. BBC News 15 September 2005. Available at: http://news.bbc.co.uk/1Zhi/world/ south_asia/4250506.stm.
7. Short RV. The evolution of human reproduction. Proc R Soc Lond B Biol Sci 1976;195:3-24.
8. Chavez-MacGregor M, van Gils CH, van der Schouw YT, Monninkhof E, van Noord PA, Peeters PH. Lifetime cumulative number of menstrual cycles and serum sex hormone levels in postmenopausal women. Breast Cancer Res Treat 2008;108:101-12.
9. Fraser HM, Baird DT. Clinical applications of LHRH analogues. Baillieres Clin Endocrinol Metab 1987;1:43-70.
10. Maggi R, Cariboni AM, Marelli MM, et al. GnRH and GnRH receptors in the pathophysiology of the human female reproductive system. Hum Reprod Update 2016;22:358-81.
11. Skorupskaite K, George JT, Anderson RA. The kisspeptin-GnRH pathway in human reproductive health and disease. Hum Reprod Update 2014;20:485-500.
12. Topaloglu AK, Tello JA, Kotan LD, et al. Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N Engl J Med 2012;366:629-35.
13. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A 2003;100:10972-76.
14. Seminara SB, Messager S, Chatzidaki EE, et al.
The GPR54 gene as a regulator of puberty. N Engl JMed 2003;349:1614-27.15. Teles MG, Bianco SD, Brito VN, et al. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 2008;358:709-15.
16. Block E. Quantitative morphological investigations of the follicular system in women; methods of quantitative determinations. Acta Anat (Basel) 1951;12:267-85.
17. Block E. Quantitative morphological investigations of the follicular system in women; variations at different ages. Acta Anat (Basel) 1952;14:108-23.
18. Block E. A quantitative morphological investigation of the follicular system in newborn female infants. Acta Anat (Basel) 1953;17:201-206.
19. Ledger WL. Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology. J Clin Endocrinol Metab 2010;95:5144-54.
20. Stouffer RL, Bishop CV, Bogan RL, Xu F, Hennebold JD. Endocrine and local control of the primate corpus luteum. Reprod Biol 2013;13:259-71.
21. Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW. Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 2000;80:1-29.
22. McDonald SE, Henderson TA, Gomez-Sanchez CE, Critchley HO, Mason JI. 11Beta-hydroxysteroid dehydrogenases in human endometrium. Mol Cell Endocrinol 2006;248:72-78.
23. Critchley HO, Saunders PT. Hormone receptor dynamics in a receptive human endometrium. Reprod Sci 2009;16:191-99.
24. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3-25
25. Talbi S, Hamilton AE, Vo KC, et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 2006; 147:1097-121.
26. Jabbour HN, Kelly RW, Fraser HM, Critchley HO. Endocrine regulation of menstruation. Endocr Rev 2006;27:17-46.
27. Gleeson N, Devitt M, Sheppard BL, Bonnar J. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding.
Br J Obstet Gynaecol 1993;100:768-71.28. Nordengren J, Pilka R, Noskova V, et al. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle. Mol Hum Reprod 2004;10:655-63.
29. Gleeson NC, Buggy F, Sheppard BL, Bonnar J. The effect of tranex- amic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding. Acta Obstet Gynecol Scand 1994;73:274-77.
30. Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004;111:734-40.
31. Maybin JA, Critchley HO, Jabbour HN. Inflammatory pathways in endometrial disorders. Mol Cell Endocrinol 2011;335:42-51.
32. Markee JE. Menstruation in intraocular transplants in the rhesus monkey. Contrib Embryol 1940;28:219-308.
33. Maybin JA, Battersby S, Hirani N, Nikitenko LL, Critchley HO, Jabbour HN. The expression and regulation of adrenomedullin in the human endometrium: a candidate for endometrial repair. Endocrinology 2011;152:2845-56.
34. Maybin JA, Hirani N, Brown P, Jabbour HN, Critchley HO. The regulation of vascular endothelial growth factor by hypoxia and prostaglandin F2α during human endometrial repair. J Clin Endocrinol Metab 2011;96:2475-83.
35. Brenner RM, Slayden OD. Molecular and functional aspects of menstruation in the macaque. Rev Endocr Metab Disord 2012;13:309-18.
36. Finn CA, Pope M. Vascular and cellular changes in the decidualized endometrium of the ovariectomized mouse following cessation of hormone treatment: a possible model for menstruation. J Endocrinol 1984;100:295-300.
37. Brasted M, White CA, Kennedy TG, Salamonsen LA. Mimicking the events of menstruation in the murine uterus. Biol Reprod 2003;69:1273-80.
38. Cousins FL, Murray A, Esnal A, Gibson DA, Critchley HO, Saunders PT. Evidence from a mouse model that epithelial cell migration and mesenchymal-epithelial transition contribute to rapid restoration of uterine tissue integrity during menstruation.
PLoS One 2014;9:e86378.39. Fraser IS, Critchley HO, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med 2011;29:383-90.
40. Munro MG, Critchley HO, Fraser IS. The FIGO classification of causes of abnormal uterine bleeding: Malcolm G. Munro, Hilary O.D. Critchley, Ian S. Fraser, for the FIGO Working Group on Menstrual Disorders. Int J Gynaecol Obstet 2011;113:3-13.
41. National Institute for Health and Care Excellence (NICE). Heavy Menstrual Bleeding. Clinical guideline [CG44]. London: NICE; 2007. Available at: https://www.nice.org.uk/guidance/CG44.
42. Royal College of Obstetricians and Gynaecologists (RCOG). National Heavy Menstrual Bleeding Audit—First Annual Report. London: RCOG; 2011. Available at: https:// www.rcog.org.uk/globalassets/documents/guidelines/research-- audit/nationalhmbaudit_1stannualreport_may2011.pdf.
43. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998;351:485-89.
44. Kouides PA, Conard J, Peyvandi F, Lukes A, Kadir R. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril 2005;84:1345-51.
45. Mahmud A, Smith P, Clark J. The role of hysteroscopy in diagnosis of menstrual disorders. Best Pract Res Clin Obstet Gynaecol 2015;29:898-907.
46. Royal College of Obstetricians and Gynaecologists (RCOG). Standards for Gynaecology—Report of a Working Party. London: RCOG; 2008. Available at: https://www.rcog.org.uk/globalassets/ documents/guidelines/wprgynstandards2008.pdf.
47. Gupta JK, Daniels JP, Middleton LJ, et al. A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial. Health Technol Assess 2015;19:i-xxv, 1-118.
48. Royal College of Obstetricians and Gynaecologists (RCOG). National Heavy Menstrual Bleeding Audit— Final Report. London: RCOG; 2014. Available at: https:// www.rcog.org.uk/globalassets/documents/guidelines/research-- audit/national_hmb_audit_final_report_july_2014.pdf.
49. Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2016;1:CD003855.